In patient samples, we observed a higher proportion of strong positive and positive PRDX1 expression in the more aggressive TFL and DLBCL as compared to the indolent FL, this difference is most pronounced in the comparison between GCB-DLBCL and FL. The gene discussed is PRDX1; the disease is diffuse large B-cell lymphoma.